TREATMENT WITH CERTOLIZUMAB PEGOL IN RA - DATA FROM THE NATIONAL REGISTRY ARTIS (ANTIRHEUMATIC THERAPIES IN SWEDEN)

被引：0
|
作者：
Chatzidionysiou, K. [1 ]
van Vollenhoven, R. [1 ]
机构：
[1] Karolinska Inst, Clintrid, Dept Rheumatol, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.3084
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：517 / 518
页数：2
相关论文
共 50 条
  • [41] SAFETY OF BIOLOGICAL THERAPIES: DATA FROM THE BIOBADAGUAY REGISTRY
    Trigueros, P. De Abreu
    Cabrera-Villalba, S.
    Melgarejo, P.
    Morel, Z.
    Roman, L.
    Ramagli, A.
    Amarilla, A.
    Cairus, C. Brunengo
    Moreno, G. Bartesaghi
    Leiva, E.
    Zarza, M.
    Rolon, R.
    Pusineri, P.
    Parodi, C.
    Valinotti, V.
    Vega, C.
    Zanotti, M.
    Consani-Fernandez, S.
    Avila, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1412 - 1413
  • [42] COMPARATIVE EFFECTIVENESS OF BLEEDING AVOIDANCE THERAPIES IN PCI PATIENTS: ANALYSIS FROM THE NATIONAL CARDIOVASCULAR DATA REGISTRY®
    Marso, Steven P.
    House, Amit Amin John A.
    Kennedy, Kevin F.
    Spertus, John A.
    Rao, Sunil V.
    Cohen, David J.
    Messenger, John C.
    Rumsfeld, John S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [43] Evaluation of Real-World Risk of Malignancies in Crohn's Disease Patients Treated With Certolizumab Pegol: Results From the SECURE Registry
    Lichtenstein, Gary R.
    Loftus, Edward V.
    Feagan, Brian G.
    Binion, David G.
    Sen, David
    Golembesky, Amanda
    Kosutic, Gordana
    Kayhan, Cem
    Spearman, Marshall
    Wolf, Douglas C.
    Lee, Scott D.
    GASTROENTEROLOGY, 2015, 148 (04) : S236 - S236
  • [44] CERTOLIZUMAB PEGOL FOR THE TREATMENT OF PSORIATIC ARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-PSA TRIAL
    Mease, P. J.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Gladman, D.
    Hoepken, B.
    Peterson, L.
    van der Heijde, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 779 - 780
  • [45] Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland
    Kumar, Namita
    Naz, Sophia
    Quinn, Mark
    Ryan, John
    Kumke, Thomas
    Sheeran, Tom
    ADVANCES IN THERAPY, 2018, 35 (09) : 1426 - 1437
  • [46] TNF-antagonist treatment and risk of hospitalisation for cardiovascular disease.: Results from the National Swedish Monitoring-Program for Biologies in Ra (ARTIS).
    Askling, Johan
    Fored, M.
    Brandt, L.
    Baecklund, E.
    Bertilsson, L.
    Cöster, L.
    Geborek, P.
    Jacobsson, L.
    Lindblad, S.
    Lysholm, J.
    Rantapaa-Dahlqvist, S.
    Saxne, T.
    van Vollenhoven, R.
    Feltelius, N.
    Klareskog, L.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S421 - S421
  • [47] CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-AXSPA TRIAL
    Van der Heijde, D.
    Dougados, M.
    Landewe, R.
    Sieper, J.
    Maksymowych, W. P.
    Rudwaleit, M.
    van den Bosch, F.
    Braun, J.
    Mease, P. J.
    Davies, O.
    Hoepken, B.
    Peterson, L.
    Deodhar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 803 - 803
  • [48] CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS: 4-YEAR OUTCOMES FROM THE RAPID-AXSPA TRIAL
    van der Heijde, D.
    Dougados, M.
    Landewe, R.
    Sieper, J.
    Maksymowych, W. P.
    Rudwaleit, M.
    van den Bosch, F.
    Braun, J.
    Mease, P. J.
    Davies, O.
    Hoepken, B.
    Peterson, L.
    Deodhar, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 779 - 779
  • [49] Certolizumab Pegol for the Treatment of Psoriasis Arthritis: 4-Year Results from the RAPID-PSA Study
    Hoepken, B.
    Mease, P. J.
    Fleischmann, R.
    Wollenhaupt, J.
    Deodhar, A.
    Gladman, D.
    Petersen, L.
    van der Heijde, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 140 - 141
  • [50] Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland
    Namita Kumar
    Sophia Naz
    Mark Quinn
    John Ryan
    Thomas Kumke
    Tom Sheeran
    Advances in Therapy, 2018, 35 : 1426 - 1437
12345